We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use ÌìÃÀÓ°Ôº, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Change to the information provided on adverse events in the Summary of Product Characteristics for Osurnia Ear Gel for Dogs.
Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
The Home Office has placed pregabalin and gabapentin to Schedule 3 of the Misuse of Drug Regulations 2001 from 1 April 2019.
More information following investigation into an increase of adverse event reports following the use of Genta-Equine 100 mg/ml Solution for Injection for Horses.
This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.
Legal requirements and good practice guidance for SQP retailers’ premises inspections.
The following detailed requirements shall apply to Requirements for Specific Marketing Authorisation Applications.
Bravecto Chewable Tablets for Dogs seized at East Midlands Airport.
Details of a new VMD Intelligence Unit and anonymous reporting.
Apply to be an authorised animal feedingstuffs manufacturer and/or distributor.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve ÌìÃÀÓ°Ôº, we’d like to know more about your visit today. .